People: Abbott Laboratories (ABT)

ABT on New York Consolidated

41.59USD
22 Oct 2014
Price Change (% chg)

$-0.80 (-1.89%)
Prev Close
$42.39
Open
$42.50
Day's High
$43.03
Day's Low
$41.48
Volume
6,986,485
Avg. Vol
4,577,887
52-wk High
$44.20
52-wk Low
$35.65

Search Stocks

Summary

Name Age Since Current Position

Miles White

59 1999 Chairman of the Board, Chief Executive Officer

Thomas Freyman

59 2004 Chief Financial Officer, Executive Vice President - Finance

Hubert Allen

48 2013 Executive Vice President, General Counsel, Secretary

Stephen Fussell

56 2013 Executive Vice President - Human Resources

Richard Ashley

70 2004 Executive Vice President - Corporate Development

Brian Blaser

49 2012 Executive Vice President - Diagnostics Products

John Capek

52 2007 Executive Vice President - Medical Devices

Michael Warmuth

51 2012 Executive Vice President - Established Pharmaceuticals

Jaime Contreras

57 2013 Senior Vice President - Core Laboratory Diagnostics, Commercial Operations

Georges De Vos

55 2013 Senior Vice President - Established Pharmaceuticals, Emerging Markets

Katherine Doyle

46 2013 Senior Vice President - U.S. Nutrition

Charles Foltz

53 2013 Senior Vice President - Abbott Vascular

Heather Mason

53 2008 Senior Vice President - Abbott Diabetes Care

Jean-Yves Pavee

50 2013 Senior Vice President - Established Pharmaceuticals, Developed Markets

Murthy Simhambhatla

48 2013 Senior Vice President - Abbott Medical Optics

J. Scott White

46 2013 Senior Vice President - International Nutrition

Robert Funck

52 2013 Vice President, Controller

Robert Alpern

63 2008 Independent Director

Roxanne Austin

53 2000 Independent Director

Sally Blount

52 2011 Independent Director

W. James Farrell

71 2006 Independent Director

Edward Liddy

68 2010 Independent Director

Nancy McKinstry

55 2011 Independent Director

Phebe Novakovic

56 2010 Independent Director

William Osborn

66 2008 Independent Director

Samuel Scott

69 2007 Independent Director

Glenn Tilton

65 2007 Independent Director

Biographies

Name Description

Miles White

Mr. Miles D. White is Chairman of the Board, Chief Executive Officer of Abbott Laboratories since 1999. He served as an executive vice president of Abbott from 1998 to 1999, as senior vice president, diagnostics operations from 1994 to 1998, and as vice president, diagnostics systems operations from 1993 to 1994. Mr. White joined Abbott in 1984. He received both his bachelor's degree in mechanical engineering and M.B.A. degree from Stanford University. He serves on the board of trustees of The Culver Educational Foundation, The Field Museum in Chicago, and Northwestern University. He currently serves as a director of Caterpillar, Inc. and McDonald's Corporation. Mr. White also served on the board of directors of Motorola, Inc. from 2005 to 2009 and Tribune Company from 2005 to 2007. Serving as Abbott's chairman of the board and chief executive officer since 1999 and having joined Abbott in 1984.

Thomas Freyman

Mr. Thomas C. Freyman is Chief Financial Officer, Executive Vice President - Finance of Abbott Laboratories. He was appointed to his current role in February 2004 and has served as Abbott's Chief Financial Officer since 2001. Mr. Freyman joined Abbott in 1979, and has served in a number of financial planning and analysis positions. In 1984, Mr. Freyman was appointed Finance Director for Abbott's European distribution center in the Netherlands. He also served as Division Controller, Corporate Materials Management, Vice President and Treasurer, and Vice President and Controller, Hospital Products Division. Prior to joining Abbott, Mr. Freyman was a Certified Public Accountant with Ernst & Whinney, Chicago. Mr. Freyman serves on the board of directors for the Chicago Botanic Garden. He is also a member of the Economic Club of Chicago, the Executives' Club of Chicago, the Healthcare Leadership Council and the S&P Corporate Ratings Issuer Council. He earned a Bachelor's degree in Accounting from the University of Illinois and a Master's degree in Management from Northwestern University.

Hubert Allen

Mr. Hubert L. Allen is Executive Vice President, General Counsel and Secretary of Abbott Laboratories., since January 2013. From 2010 to 2012 — Divisional Vice President and Associate General Counsel, Established Pharmaceuticals; 2009 to 2010 — Divisional Vice President and Associate General Counsel, Proprietary Pharmaceuticals; 2007 to 2009 — Section Head, Legal, Abbott Nutrition.

Stephen Fussell

Mr. Stephen R. Fussell is Executive Vice President - Human Resources of Abbott Laboratories. Previously, he served as Vice President, Compensation and Development. He joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. Prior to joining Abbott, Mr. Fussell was Vice President, Total Compensation and Workforce Information at Nestlé USA. Mr. Fussell is a board member for the Clara Abbott Foundation and the Abbott Fund. He earned a Bachelor's degree in Management and Administration from Louisiana State University in Baton Rouge.

Richard Ashley

Mr. Richard W. Ashley is Executive Vice President - Corporate Development of Abbott Laboratories since 2004. His responsibilities include various aspects of corporate strategic planning and business development. Ashley was appointed to his current position in February of 2004. Prior to joining Abbott, he was a Senior Director at McKinsey and Company, a former Managing Partner of the firm's Chicago office, and Head of the firm's Global Leadership and Organization practice. During his 31 years with McKinsey, Ashley consulted with clients in healthcare, energy and industrial manufacturing industries across a wide range of business and organizational issues. Mr. Ashley is a member of the Executive Committee of the board of directors of Junior Achievement of Chicago and a former member of the Civic Committee of the Commercial Club of Chicago. He is also a member of the American Bar Association and the Wisconsin Bar Association. He earned a Bachelor's Degree in Political Science and Master's degree in Business Administration from Northwestern University. He also holds a Juris Doctorate from the University of Wisconsin Law School.

Brian Blaser

Mr. Brian J. Blaser is Executive Vice President - Diagnostics Products of Abbott Laboratories, since June 1, 2012. He was appointed to his current position in June 2010. Previously, Mr. Blaser served as Vice President, Diagnostics Operations; Divisional Vice President, Global Operations; and Divisional Vice President, Reagent Manufacturing, all for Abbott Diagnostics. Prior to joining Abbott, Mr. Blaser held several positions of increasing responsibility in engineering, finance and operations at Johnson & Johnson, Eastman Kodak and General Motors. He earned a bachelor's degree in mechanical engineering technology from the University of Dayton and a master's degree in business administration from Rochester Institute of Technology.

John Capek

Dr. John M. Capek, Ph.D., is Executive Vice President - Medical Devices of Abbott Laboratories since July 2007. He is responsible for Abbott's Vascular, Diabetes Care, Ophthalmology and Animal Health businesses. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Michael Warmuth

Mr. Michael J. Warmuth is Executive Vice President - Established Pharmaceuticals of Abbott Laboratories, since November 2012. Most recently, Mr. Warmuth served as Senior Vice President, Established Pharmaceuticals, which previously operated as part of Abbott’s global pharmaceutical business. Mr. Warmuth joined Abbott in 1986 as part of Abbott's manufacturing professional development program. He served in a variety of management roles including Senior Vice President, Diagnostics, heading Abbott’s global core laboratory Diagnostics business; Vice President and General Manager, Hematology, in Abbott's Diagnostics business; Vice President, Global Engineering Services; Divisional Vice President of Pharmaceutical Operations; and Divisional Vice President of Corporate Quality Operations. He earned a bachelor's degree in business administration from the University of Wisconsin-Whitewater and a master's degree in business administration from Northwestern University.

Jaime Contreras

Mr. Jaime Contreras is Senior Vice President - Core Laboratory Diagnostics, Commercial Operations. He was elected as Corporate Officer in 2003.

Georges De Vos

Katherine Doyle

Ms. Katherine C. Doyle is Senior Vice President - U.S. Nutrition of Abbott Laboratories since March 2013. Previously, she served as Vice President, Pediatric Products. Prior to joining Abbott, she was a principal of McKinsey & Company, Inc. Ms. Doyle brings more than 20 years of experience to Abbott, having worked with retailers and consumer brand leaders across North America, Europe, Africa and Asia. During her tenure at McKinsey, she served as the leader of the consulting firm’s Merchandising Practice, developing global growth strategies, marketing plans and merchandising practices for retailers and consumer brand leaders around the world. She earned a bachelor’s degree of science and business administration from Georgetown University and a master's degree in economics from the Johns Hopkins School of Advanced International Studies, where she spent a year studying in Bologna, Italy and at the Universite de Paris-Sorbonne. She was also a joint economics fellow at Harvard University’s Kennedy School of Government and Harvard Business School.

Charles Foltz

Mr. Charles D. Foltz is Senior Vice President - Abbott Vascular of Abbott Laboratories since March 2013. Previously, he was Vice President, Vascular Products Operations at Abbott Vascular. Mr. Foltz joined Abbott in 1983 as part of Abbott’s financial professional development program. He has held various management positions including, Divisional Vice President, Guidant Integration; Divisional Vice President and General Manager, Divisional Vice President Sales and Marketing and Vice President Vascular Solutions for Abbott Vascular. Mr. Foltz serves on the board of directors of the Clara Abbott Foundation. He earned a bachelor's degree in accounting from Michigan State University.

Heather Mason

Ms. Heather L. Mason is Senior Vice President - Abbott Diabetes Care of Abbott Laboratories since May 2008. Ms. Mason previously served as Vice President, Latin American Operations in Abbott's international pharmaceutical business. Ms. Mason joined Abbott in 1990. She held a number of positions in Abbott's U.S. pharmaceutical business, including oversight of Abbott's specialty pharmaceuticals, the diabetes/metabolics and oncology franchises, and managed health care. Ms. Mason also served as Vice President, International Marketing in Abbott's international pharmaceutical business. Prior to joining Abbott, Ms. Mason worked for Quaker Oats and FMC Corporation. Ms. Mason is an advisory board member of the Healthcare Businesswomen’s Association and Corporate Advisor for the Juvenile Diabetes Research Foundation and American Diabetes Association. She earned a Bachelor's degree in Engineering from the University of Michigan and a Master's degree in Business Administration from the University of Chicago.

Jean-Yves Pavee

Murthy Simhambhatla

Dr. Murthy Simhambhatla, Ph.D., is Senior Vice President - Abbott Medical Optics of Abbott Laboratories, since January 2013. Previously, he served as General Manager of the Ibis Biosciences unit of Abbott Diagnostics. Dr. Simhambhatla joined Abbott in 2006 through its acquisition of Guidant Corporation, as Divisional Vice President and General Manager for Drug Eluting Stents. He also served as General Manager for commercial operations in Australia and New Zealand for Abbott Vascular. Before joining Guidant, Dr. Simhambhatla worked in research and development at Raychem Corporation in Menlo Park, CA. He has a bachelor's degree in chemical engineering from Anna University in India and master’s and doctorate degrees in polymer engineering from the University of Akron.

J. Scott White

Mr. J. Scott White is Senior Vice President - International Nutrition of Abbott Laboratories. He served as Senior Vice President, U.S. Nutrition. He has been Division Vice President and Regional Director for Latin America, Abbott Nutrition International from 2007 to 2009 and Division Vice President and General Manager for Pediatric Nutrition, Abbott Nutrition International from 2005 to 2007.

Robert Funck

Mr. Robert E. Funck serves as Vice President, Controller of Abbott Laboratories. Mr. Funck has served as the Company’s Vice President, Chief Ethics and Compliance Officer since 2009, as Vice President, Internal Audit from 2007 to 2009, and as Vice President and Treasurer from 2005 to 2007. Mr. Funck became a corporate officer in 2005. Mr. Funck joined the Company in 1987.

Robert Alpern

Dr. Robert J. Alpern, M.D., is Independent Director of Abbott Laboratories. Dr. Alpern has served as the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine since June 2004. From July 1998 to June 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. Dr. Alpern also serves as a Director of AbbVie Inc. and as a Director on the Board of Yale—New Haven Hospital. Dr. Alpern as the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine, Dean of The University of Texas Southwestern Medical Center, and as a Director on the Board of Yale—New Haven Hospital, Dr. Alpern contributes valuable insights to the Board through his medical and scientific expertise and his knowledge of the health care environment and the scientific nature of Abbott's key research and development initiatives.

Roxanne Austin

Mrs. Roxanne S. Austin is Independent Director of Abbott Laboratories. Ms. Austin is President of Austin Investment Advisors, a private investment and consulting firm, a position she has held since 2004. From July 2009 through July 2010, Ms. Austin also served as the President and Chief Executive Officer of Move Networks, Inc., a provider of Internet television services. Ms. Austin served as President and Chief Operating Officer of DIRECTV, Inc. from June 2001 to December 2003. Ms. Austin also previously served as Executive Vice President and Chief Financial Officer of Hughes Electronics Corporation and as a partner of Deloitte & Touche LLP. Ms. Austin is also a Director of AbbVie Inc., Target Corporation, Teledyne Technologies, Inc. and Telefonaktiebolaget LM Ericsson.

Sally Blount

Ms. Sally E. Blount, Ph.D., is Independent Director of Abbott Laboratories. She has served as Dean of the J.L. Kellogg Graduate School of Management at Northwestern University since July 2010. From 2004 to 2010, she served as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business. Ms. Blount joined the faculty of New York University's Leonard N. Stern School of Business in 2001 and was the Abraham L. Gitlow Professor of Management and Organizations. Prior to joining NYU in 2001, Ms. Blount held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001.

W. James Farrell

Mr. W. James Farrell is Independent Director of Abbott Laboratories. Mr. Farrell served as the chairman of Illinois Tool Works Inc. from 1996 to 2006 and as its chief executive officer from 1995 to 2005. He currently serves on the board of directors of Allstate Insurance Company, UAL Corporation, and 3M. Mr. Farrell also served on the board of directors of Kraft Foods, Inc. from 2001 to 2006 and Sears, Roebuck and Company from 1999 to 2005. He has been chairman and chief executive officer of Illinois Tool Works.

Edward Liddy

Mr. Edward M. Liddy is Independent Director of Abbott Laboratories. Mr. Liddy has been a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC since January 2010, having also been a partner at such firm from April to September 2008. From September 2008 to August 2009, Mr. Liddy was the interim chairman and chief executive officer of American International Group, Inc. (AIG), a global insurance and financial services holding company. He served at AIG at the request of the U.S. Department of the Treasury in conjunction with the U.S. Government's actions to provide stability to AIG and certain other financial service firms. From January 1999 to April 2008, Mr. Liddy served as chairman of the board of the Allstate Corporation. He served as chief executive officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and chief operating officer from August 1994 to January 1999. Mr. Liddy currently serves on the board of directors of 3M Company and The Boeing Company. In addition, Mr. Liddy formerly served on the boards of The Kroger Co. from 1996 to 2006, The Goldman Sachs Group, Inc. from 2003 to 2008, and The Boeing Company from 2007 to 2008. Mr. Liddy received his undergraduate degree from Catholic University and his Masters of Business Administration from George Washington University. He has been chairman and chief executive officer of Allstate Corporation and American International Group, Inc.

Nancy McKinstry

Ms. Nancy McKinstry is Independent Director of Abbott Laboratories. She has been the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V. since September 2003 and a member of its Executive Board since June 2001. Ms. McKinstry serves on the Board of Directors of Sanoma Corporation. Ms. McKinstry also serves on the Advisory Board of the University of Rhode Island, the Advisory Council of the Amsterdam Institute of Finance, the Board of Overseers of Columbia Business School and the Advisory Board of the Harrington School of Communication and Media. Ms. McKinstry served on the Board of Directors of Telefonieaktiebolaget LM Ericsson (LM Ericsson Telephone Company) from 2004 to 2012. Ms. McKinstry also served on the Board of Directors of MortgageIT Holdings, Inc. from 2004 to 2007.

Phebe Novakovic

Ms. Phebe N. Novakovic is Independent Director of Abbott Laboratories. Ms. Novakovic has been Chairman and Chief Executive Officer of General Dynamics Corporation since January 1, 2013. Previously, she served as President and Chief Operating Officer from May 2012 to December 2012 and as Executive Vice President, Marine Systems of General Dynamics from May 2010 to May 2012. From May 2005 to April 2010, Ms. Novakovic served as its Senior Vice President—Planning and Development. She was elected Vice President of General Dynamics in October 2002 after joining the company in May 2001. Previously, Ms. Novakovic was Special Assistant to the Secretary and Deputy Secretary of Defense, and had been a Deputy Associate Director of the Office of Management and Budget.

William Osborn

Mr. William A. Osborn is Independent Director of Abbott Laboratories. Mr. Osborn was Chairman of Northern Trust Corporation from 1995 through 2009 and served as its Chief Executive Officer from 1995 through 2007. Mr. Osborn currently serves as a Director of Caterpillar Inc. and General Dynamics Corporation. He is Chairman of the Board of Trustees of Northwestern University. Mr. Osborn served on the Board of Directors of Nicor, Inc. from 1999 to 2006 and on the Board of Directors of Tribune Company from 2001 to 2012. He has been the Chairman and Chief Executive Officer of Northern Trust Corporation and The Northern Trust Company, Mr. Osborn acquired broad experience in successfully overseeing complex global businesses operating in highly regulated industries.

Samuel Scott

Mr. Samuel C. Scott, III., is Independent Director of Abbott Laboratories., since 2007. Mr. Scott retired as Chairman, President and Chief Executive Officer of Corn Products International in 2009. He served as Chairman, President, and Chief Executive Officer from February 2001 until he retired in May of 2009. He was President and Chief Operating Officer from January 1998 until February 2001. He was President of the Corn Refining Division of CPC International from 1995 through 1997, when CPC International spun off Corn Products International as a separate corporation. Mr. Scott currently serves on the Board of Directors of Bank of New York Mellon Corporation and Motorola Solutions, Inc. He has been the Chairman, President and Chief Executive Officer of Corn Products International, Mr. Scott acquired valuable business, leadership and management experience, including critical insights into matters relevant to a major public company and experience in finance and capital markets matters.

Glenn Tilton

Mr. Glenn F. Tilton is an Independent Director of Abbott Laboratories. In 2011, Mr. Tilton became Chairman of the Midwest for JPMorgan Chase & Co. and a member of its companywide Executive Committee. From October 2010 to December 2012, Mr. Tilton also served as the Non-Executive Chairman of the Board of United Continental Holdings, Inc. From September 2002 to October 2010, he served as Chairman, President and Chief Executive Officer of UAL Corporation, a holding company, and Chairman and Chief Executive Officer of United Air Lines, Inc., an air transportation company and wholly owned subsidiary of UAL Corporation. Mr. Tilton is also a Director of AbbVie Inc. and Phillips 66. Mr. Tilton also served on the Board of Directors of Lincoln National Corporation from 2002 to 2007, of TXU Corporation from 2005 to 2007, of Corning Incorporated from 2010 to 2012, and of United Continental Holdings, Inc. from 2001 to 2013. He has been Chairman of the Midwest for JPMorgan Chase & Co. and having previously served as Non-Executive Chairman of the Board of United Continental Holdings, Inc., and Chairman, President, and Chief Executive Officer of UAL Corporation and United Air Lines, Vice Chairman of Chevron Texaco and as Interim Chairman of Dynegy, Inc., Mr. Tilton acquired strong management experience overseeing complex multinational businesses operating in highly regulated industries, as well as expertise in finance and capital markets matters.
Search Stocks